Who owns Coya Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of COYA from SEC Form 13F filings across 42 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 42 institutions disclosed 5.5M shares of Coya Therapeutics, Inc. worth $32.1M — about 23.4% of shares outstanding; the largest disclosed holder is DME Capital Management, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
42
13F holders
$32.1M
value, 2026 filers
23.4%
of shares outstanding (5.5M sh)
5
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of COYA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | DME Capital Management, LP | 2.3M | $13.7M | 0.3% | 10% | 0.0% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 842,220 | $4.9M | 0.0% | 3.6% | -50.2% |
| 3 | AIGH Capital Management LLC | 631,912 | $3.7M | 0.2% | 2.7% | -35.2% |
| 4 | MARSHALL WACE, LLP | 249,793 | $1.5M | 0.0% | 1.1% | +10.6% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 228,243 | $1.3M | 0.0% | 1% | -2.2% |
| 6 | Prosight Management, LP | 170,000 | $994,500 | 0.2% | 0.7% | -59.6% |
| 7 | VANGUARD FIDUCIARY TRUST CO | 129,551 | $757,873 | 0.0% | 0.6% | -7.4% |
| 8 | JONES FINANCIAL COMPANIES LLLP | 110,910 | $610,005 | 0.0% | 0.5% | +146.7% |
| 9 | BlackRock, Inc. | 102,408 | $599,087 | 0.0% | 0.4% | +23.7% |
| 10 | PRELUDE CAPITAL MANAGEMENT, LLC | 101,330 | $592,781 | 0.0% | 0.4% | 0.0% |
| 11 | ROYAL BANK OF CANADA | 93,414 | $546,000 | 0.0% | 0.4% | +597.5% |
| 12 | MORGAN STANLEY | 82,106 | $480,320 | 0.0% | 0.4% | -4.2% |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 61,006 | $356,885 | 0.0% | 0.3% | +55.2% |
| 14 | NORTHERN TRUST CORP | 45,072 | $263,671 | 0.0% | 0.2% | +11.5% |
| 15 | Cetera Investment Advisers | 34,000 | $198,900 | 0.0% | 0.1% | +13.3% |
| 16 | Squarepoint Ops LLC | 33,260 | $194,571 | 0.0% | 0.1% | -17.8% |
| 17 | UBS Group AG | 33,088 | $193,565 | 0.0% | 0.1% | -14.2% |
| 18 | GOLDMAN SACHS GROUP INCNEW | 26,180 | $153,153 | 0.0% | 0.1% | new |
| 19 | GHP Investment Advisors, Inc. | 26,171 | $153,101 | 0.0% | 0.1% | 0.0% |
| 20 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 20,626 | $120,662 | 0.0% | 0.1% | 0.0% |
| 21 | OPPENHEIMER & CO INC | 18,000 | $105,300 | 0.0% | 0.1% | 0.0% |
| 22 | Jump Financial, LLC | 17,300 | $101,205 | 0.0% | 0.1% | -17.6% |
| 23 | CITADEL ADVISORS LLC | 13,105 | $76,664 | 0.0% | 0.1% | -22.3% |
| 24 | Allworth Financial LP | 13,000 | $76,050 | 0.0% | 0.1% | +1200.0% |
| 25 | RAYMOND JAMES FINANCIAL INC | 10,225 | $59,816 | 0.0% | 0% | -12.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.